A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
Definition: This study will compare the drug GEMZAR to a combination of GEMZAR plus ALIMTA for the treatment of cancer of the pancreas. Patients may be able to participate in this study if they have cancer in their pancreas that cannot be removed by surgery OR that has spread to a new site in their body.
Inclusion Criteria:
Exclusion Criteria:
Capitol Federal, Buenos Aires, Argentina
Ciudad de Buenos Aires, Argentina
Kingswood Penrith, New South Wales, Australia
Saint Veit Glan, Austria
Neustadt/Suedharz, Germany
Yungkang City, Tainan, Taiwan
Estado Aragua, Maracay, Venezuela